triamterene has been researched along with Lupus Erythematosus, Systemic in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kast, RE | 1 |
Altschuler, EL | 1 |
Berbis, P | 1 |
Vernay-Vaisse, C | 1 |
Privat, Y | 1 |
2 other studies available for triamterene and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells: consideration of triamterene to treat lupus.
Topics: B-Lymphocytes; Dendritic Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lupus Erythematosus, S | 2010 |
[Subacute cutaneous lupus observed during treatment with thiazide diuretics].
Topics: Aged; Benzothiadiazines; Diuretics; Drug Combinations; Female; Humans; Lupus Erythematosus, Systemic | 1986 |